ERNEST MARIO - 21 May 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
21 May 2024
Net transactions value
+$279,000
Form type
4
Filing time
23 May 2024, 19:11:13 UTC
Previous filing
10 Jan 2024
Next filing
10 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Exercise of in-the-money or at-the-money derivative security $279,000 +62,000 +50% $4.50 186,566 21 May 2024 Direct
holding SLNO Common Stock 21,789 21 May 2024 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -62,000 -100% $0.000000* 0 21 May 2024 Common Stock 62,000 $4.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares beneficially owned has been adjusted pursuant to an internal review of the Reporting Person's holdings.
F2 The shares are held by Mildred Mario Nonexempt Trust, of which the Reporting Person is a co-trustee.